Literature DB >> 19567599

Inhaled corticosteroids in COPD: the case against.

S Suissa, P J Barnes.   

Abstract

Mesh:

Substances:

Year:  2009        PMID: 19567599     DOI: 10.1183/09031936.00190908

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  42 in total

Review 1.  Cost effectiveness of pharmacological maintenance treatment for chronic obstructive pulmonary disease: a review of the evidence and methodological issues.

Authors:  Maureen P M H Rutten-van Mölken; Lucas M A Goossens
Journal:  Pharmacoeconomics       Date:  2012-04       Impact factor: 4.981

Review 2.  Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease (COPD).

Authors:  Nobuyuki Horita; Atsushi Goto; Yuji Shibata; Erika Ota; Kentaro Nakashima; Kenjiro Nagai; Takeshi Kaneko
Journal:  Cochrane Database Syst Rev       Date:  2017-02-10

3.  Counterpoint: were industry-sponsored roflumilast trials appropriate? No.

Authors:  Jason Rho; Nancy Ho; Vinay Prasad
Journal:  Chest       Date:  2014-05       Impact factor: 9.410

4.  2016 Respiratory Effectiveness Group Annual Summit Report-impact & influence of real-world respiratory evidence.

Authors:  Alison Chisholm; Nemr Eid; Bernardino Alcázar-Navarrete; Aji Barot; George Christoff; David B Price
Journal:  J Thorac Dis       Date:  2016-07       Impact factor: 2.895

Review 5.  Glucocorticosteroids: current and future directions.

Authors:  Peter J Barnes
Journal:  Br J Pharmacol       Date:  2011-05       Impact factor: 8.739

Review 6.  Outcome measures in chronic obstructive pulmonary disease (COPD): strengths and limitations.

Authors:  Thomas Glaab; Claus Vogelmeier; Roland Buhl
Journal:  Respir Res       Date:  2010-06-17

Review 7.  An overview of the benefits and drawbacks of inhaled corticosteroids in chronic obstructive pulmonary disease.

Authors:  Sonal Singh; Yoon K Loke
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2010-08-09

8.  Point of Care Portable Spirometry in the Diagnosis and Treatment of Inpatients with Chronic Obstructive Pulmonary Disease.

Authors:  Donald Tran; Melvin Lim; Sara Vogrin; Lata Jayaram
Journal:  Lung       Date:  2020-01-01       Impact factor: 2.584

9.  Initiating Low-Value Inhaled Corticosteroids in an Inception Cohort with Chronic Obstructive Pulmonary Disease.

Authors:  Laura J Spece; Lucas M Donovan; Matthew F Griffith; Thomas Keller; Laura C Feemster; Nicholas L Smith; David H Au
Journal:  Ann Am Thorac Soc       Date:  2020-05

10.  ICS and COPD: time to clear the air.

Authors:  Paul A Ford; Richard E K Russell; Peter J Barnes
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2009-08-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.